Lenalidomide as salvage therapy after allo-SCT for multiple myeloma is effective and leads to an increase of activated NK (NKp44+) and T (HLA-DR+) cells

✍ Scribed by Lioznov, M; El-Cheikh, J; Hoffmann, F; Hildebrandt, Y; Ayuk, F; Wolschke, C; Atanackovic, D; Schilling, G; Badbaran, A; Bacher, U

• Book ID: 109840740
• Publisher: Nature Publishing Group
• Year: 2009
• Tongue: English
• Weight: 149 KB
• Volume: 45
• Category: Article
• ISSN: 0007-1188
• DOI: 10.1038/bmt.2009.155